Aprecia Pharmaceuticals Private Limited, a active private limited company, was established on 16 May 2017 in Lucknow, Uttar Pradesh, India. Engaging in other services within the business services sector, it holds CIN: U74999UP2017PTC093123. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Formerly known as Aminabad Surgical Private Limited. It upholds a compliant status. Its leadership includes Muneeb Alvi (Director), Mohammad Meesam Khan (Additional Director). Past directors included Syed Kamran Ahsan, Mohammad Asif Khan, Mohammad Yasir Arafat. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 005, Grandeur Apartment Building No.6 Dalibagh, Lucknow, Uttar Pradesh, 226001.
U74999UP2017PTC093123
093123
16 May 2017
₹1.00 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Aprecia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Muneeb Alvi | Director | 16 May 2017 | Current |
| Mohammad Meesam Khan | Additional Director | 15 Dec 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jan 2024 | Past |
| Pramod Abcsdd | Director | 08 Jan 2024 | Past |
| Pramod Abcsdd | Director | 25 Jun 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aprecia Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 13.46% decrease. The company also saw a slight improvement in profitability, with a 4.89% increase in profit. The company's net worth Soared by an impressive increase of 221.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Aprecia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aprecia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aprecia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprecia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aprecia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Aprecia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
Progress on Mohammad Meesam Khan was appointed as a Additional Director was appointed as a Additional Director on 15 Dec 2023 & has been associated with this company since 1 year 11 months . was documented.
Progress on Muneeb Alvi was appointed as a Director was appointed as a Director on 16 May 2017 & has been associated with this company since 8 years 6 months . was documented.
Progress on Aprecia Pharmaceuticals Private Limited was registered on 16 May 2017 with Roc Kanpur & aged 8 years 6 months as per MCA records. was documented.
The CIN of Aprecia Pharmaceuticals Private Limited is U74999UP2017PTC093123.
Aprecia Pharmaceuticals Private Limited is headquartered at 005, Grandeur Apartment Building No.6 Dalibagh, Lucknow, Uttar Pradesh, 226001.
Aprecia Pharmaceuticals Private Limited was incorporated on 16 May 2017.
The current directors of Aprecia Pharmaceuticals Private Limited are
The primary industry of Aprecia Pharmaceuticals Private Limited is Business Services.
Aprecia Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aprecia Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Aprecia Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX